Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival
Molecular Carcinogenesis Aug 29, 2017
Xu Y, et al. – The assumption under exploration was that the genetic variants of the metzincin metallopeptidase family genes correlated with cutaneous melanoma (CM)–specific survival (CMSS). The inference drawn was that these genetic variants possibly served as promising prognostic biomarkers for CMSS.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
